Balance Labs, Inc. BLNC
$1.55
-$0.02-1.27%
OTC PK
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -77.68% | 445.00% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -77.68% | 445.00% | |||
| Cost of Revenue | -1.65% | -96.26% | |||
| Gross Profit | -4.01% | 96.52% | |||
| SG&A Expenses | -10.37% | -61.47% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -2.48% | -95.91% | |||
| Operating Income | -2.56% | 96.17% | |||
| Income Before Tax | -233.18% | 100.63% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -233.18% | 100.63% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -233.18% | 100.63% | |||
| EBIT | -2.56% | 96.17% | |||
| EBITDA | -- | -- | |||
| EPS Basic | -234.21% | 100.51% | |||
| Normalized Basic EPS | -1.49% | 96.48% | |||
| EPS Diluted | -234.21% | 100.51% | |||
| Normalized Diluted EPS | -1.49% | 96.48% | |||
| Average Basic Shares Outstanding | 0.00% | 24.81% | |||
| Average Diluted Shares Outstanding | -0.14% | 24.99% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||